We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.23B
AUM Growth
+$348M
Cap. Flow
+$172M
Cap. Flow %
7.72%
Top 10 Hldgs %
19.36%
Holding
1,755
New
109
Increased
939
Reduced
649
Closed
58

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$14.5M
2
AMGN icon
Amgen
AMGN
+$11.6M
3
ABBV icon
AbbVie
ABBV
+$10.2M
4
CELG
Celgene Corp
CELG
+$8.88M
5
BIIB icon
Biogen
BIIB
+$7.99M

Sector Composition

Rank Sector Weight
1 Healthcare 24.35%
2 Technology 12.32%
3 Financials 9.33%
4 Industrials 8.44%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUBG icon
626
HUB Group
HUBG
$3.01B
$854K 0.04%
42,820
+10,698
+33% +$200K
KR icon
627
Kroger
KR
$34.8B
$854K 0.04%
43,224
+6,078
+16% +$126K
PTEN icon
628
Patterson-UTI
PTEN
$3.87B
$854K 0.04%
33,724
+794
+2% +$19K
RBBN icon
629
Ribbon Communications
RBBN
$354M
$852K 0.04%
54,107
+25,321
+88% +$391K
WTS icon
630
Watts Water Technologies
WTS
$11.5B
$852K 0.04%
13,766
-3,724
-21% -$216K
MRSH
631
Marsh
MRSH
$86.3B
$851K 0.04%
17,603
-83
-0.5% -$3.85K
BSX icon
632
Boston Scientific
BSX
$65.8B
$848K 0.04%
70,578
+3,487
+5% +$41.2K
CHE icon
633
Chemed
CHE
$6.78B
$848K 0.04%
11,069
+2,859
+35% +$211K
SVC
634
Service Properties Trust
SVC
$1.1B
$847K 0.04%
6,309
+3
+0% +$417
ARNA
635
DELISTED
Arena Pharmaceuticals Inc
ARNA
$847K 0.04%
14,477
+3,048
+27% +$159K
NDSN icon
636
Nordson
NDSN
$16.5B
$846K 0.04%
11,381
+1,268
+13% +$92.3K
PLXS icon
637
Plexus
PLXS
$6.81B
$843K 0.04%
19,469
-1,941
-9% -$76.9K
SLH
638
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
$840K 0.04%
11,877
+643
+6% +$40.2K
EXPD icon
639
Expeditors International
EXPD
$22.9B
$839K 0.04%
18,953
+2,409
+15% +$105K
CBOE icon
640
Cboe Global Markets
CBOE
$29.8B
$838K 0.04%
16,133
+1,245
+8% +$62.8K
OMC icon
641
Omnicom Group
OMC
$22.7B
$838K 0.04%
11,271
+2,313
+26% +$159K
KALU icon
642
Kaiser Aluminum
KALU
$2.67B
$837K 0.04%
11,914
-936
-7% -$64K
VHC icon
643
VirnetX Holding Corp
VHC
$52.3M
$837K 0.04%
2,156
+961
+80% +$383K
CROX icon
644
Crocs
CROX
$6.69B
$833K 0.04%
52,323
+16,003
+44% +$213K
SAFM
645
DELISTED
Sanderson Farms Inc
SAFM
$833K 0.04%
11,521
-1,144
-9% -$76.2K
RLI icon
646
RLI Corp
RLI
$5.68B
$830K 0.04%
34,080
-9,340
-22% -$222K
NI icon
647
NiSource
NI
$22.4B
$828K 0.04%
64,058
+1,202
+2% +$14.9K
HII icon
648
Huntington Ingalls Industries
HII
$11.3B
$826K 0.04%
9,182
+561
+7% +$43.4K
M icon
649
Macy's
M
$6.15B
$823K 0.04%
15,419
+1,866
+14% +$90.4K
PDCE
650
DELISTED
PDC Energy, Inc.
PDCE
$822K 0.04%
15,439
-967
-6% -$59K

Similar funds

Profund Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Profund Advisors held 1,755 positions worth $2.23B, up 18% from $1.88B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Profund Advisors deployed $172M of net new capital in Q4 2013, opening 109 new positions and adding to 939 existing holdings. Its largest new stake was Ambev: 287,712 shares worth $2.12M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was ARM HOLDINGS PLC ADS, an estimated $2.18M trimmed.

  • Profund Advisors's largest Q4 2013 buy was Ambev: 287,712 shares worth $2.12M.
  • Profund Advisors added most to Gilead Sciences in Q4 2013, an estimated $14.5M increase.
  • Profund Advisors's biggest Q4 2013 reduction was ARM HOLDINGS PLC ADS, cutting an estimated $2.18M.
  • Profund Advisors fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $2.1M.
  • Profund Advisors's ten largest holdings make up 19% of its $2.23B portfolio in Q4 2013.
  • Profund Advisors opened 109 new positions and closed 58 in Q4 2013.
  • Profund Advisors's portfolio value rose 18% quarter-over-quarter to $2.23B.

Based on Profund Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.